Hikma Pharmaceuticals PLC (Hikma) has acquired six products from Boehringer Ingelheim GmbH (Boehringer Ingelheim), for an aggregate consideration of €3 million.
Boehringer Ingelheim is a related party of Hikma for the purposes of the UKLA Listing Rules (LRs) by virtue of its 17 percent shareholding in Hikma.
Hikma Pharmaceuticals PLC (Hikma) has acquired six products from Boehringer Ingelheim GmbH (Boehringer Ingelheim), for an aggregate consideration of €3 million.
Boehringer Ingelheim is a related party of Hikma for the purposes of the UKLA Listing Rules (LRs) by virtue of its 17 percent shareholding in Hikma.
No comments:
Post a Comment